EMA/FVE info session on restrictions of certain antimicrobials, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 May 2024, 15:00 (CEST) to 23 May 2024, 16:00 (CEST)

Human medicines European public assessment report (EPAR): Ranexa (previously Latixa), ranolazine, Date of authorisation: 08/07/2008, Revision: 23, Status: Authorised

Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)

Human medicines European public assessment report (EPAR): Cancidas (previously Caspofungin MSD), caspofungin, Date of authorisation: 23/10/2001, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Aerinaze, desloratadine,pseudoephedrine, Date of authorisation: 30/07/2007, Revision: 23, Status: Authorised

Update webinar on Regulatory Procedure Management for Product Lifecycle Management on IRIS, Online, from 13 February 2024, 10:00 (CET) to 13 February 2024, 11:30 (CET)

Variations not requiring assessment (veterinary medicines)

Focus group on veterinary pharmacovigilance reporting in poultry, European Medicines Agency, Amsterdam, the Netherlands, 11 October 2023

Orphan designation: fidanacogene elaparvovec Treatment of haemophilia B, 19/11/2018 Withdrawn

Orphan designation: Veliparib Treatment of ovarian cancer, 17/12/2010 Withdrawn